Literature DB >> 18845301

Elevated C-reactive protein levels and metabolic syndrome in the elderly: The role of central obesity data from the InChianti study.

Giovanni Zuliani1, Stefano Volpato, Matteo Galvani, Alessandro Blè, Stefania Bandinelli, Anna Maria Corsi, Fulvio Lauretani, Marcello Maggio, Jack M Guralnik, Renato Fellin, Luigi Ferrucci.   

Abstract

Metabolic syndrome (MS) and "low grade" systemic inflammation (LGSI) are very common findings in the older population. Although MS and LGSI have been associated in adults, it is not known what is the real contribution of MS, and its single components, to LGSI in older persons, due to the potential confounding effect of comorbidity and aging. We investigated the relationship between increased C-reactive protein (CRP) plasma levels, a marker of LGSI, and MS in 1044 older (> or =65 years) community dwelling Italian individuals enrolled the InChianti study. Metabolic syndrome was defined by the NCEP-ATP III-AHA/NHLBI criteria. High sensitivity CRP (hs.CRP) levels were measured by enzyme-linked immunosorbent assay, and defined as high when >3mg/L. The overall prevalence of MS was 31%. The prevalence of high hs.CRP was 54.5% in subjects with, and 41.3% in those without MS (p<0.001). MS was associated with high hs.CRP levels after adjustment for age, gender, and comorbidity (OR: 1.93, 95% CI: 1.46-2.55). Compared to subjects with MS and no LGSI, individuals with MS and LGSI were characterized by higher waist circumference, BMI, and HOMA score. Multivariate logistic regression analysis confirmed the association between waist circumference and high hs.CRP levels in subjects with MS (waist circumference III vs. I tertile OR: 2.60, 95% CI: 1.79-3.77) independent of age, gender, and important confounding variables including comorbidity. Additional analyses, conducted with and without dichotomization of hs.CRP levels, confirmed the central role of waist circumference in the LGSI phenomenon, independent of gender and diagnosis of MS. We conclude that in older individuals, MS is associated with LGSI, but the association is mainly supported by a strong independent correlation between waist circumference and high hs.CRP levels. In the absence of this specific MS component, it seems that the contribution of MS to LGSI would be modest at best.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18845301      PMCID: PMC2710530          DOI: 10.1016/j.atherosclerosis.2008.07.038

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  44 in total

1.  Bone-muscle strength indices for the human lower leg.

Authors:  J Rittweger; G Beller; J Ehrig; C Jung; U Koch; J Ramolla; F Schmidt; D Newitt; S Majumdar; H Schiessl; D Felsenberg
Journal:  Bone       Date:  2000-08       Impact factor: 4.398

2.  Elevated C-reactive protein levels in overweight and obese adults.

Authors:  M Visser; L M Bouter; G M McQuillan; M H Wener; T B Harris
Journal:  JAMA       Date:  1999-12-08       Impact factor: 56.272

3.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Wayne H Giles; William H Dietz
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

Review 4.  Fat and protein redistribution with aging: metabolic considerations.

Authors:  B Beaufrère; B Morio
Journal:  Eur J Clin Nutr       Date:  2000-06       Impact factor: 4.016

5.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  A Festa; R D'Agostino; G Howard; L Mykkänen; R P Tracy; S M Haffner
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

6.  Association between C-reactive protein and features of the metabolic syndrome: a population-based study.

Authors:  M Fröhlich; A Imhof; G Berg; W L Hutchinson; M B Pepys; H Boeing; R Muche; H Brenner; W Koenig
Journal:  Diabetes Care       Date:  2000-12       Impact factor: 19.112

7.  Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study.

Authors:  L Ferrucci; S Bandinelli; E Benvenuti; A Di Iorio; C Macchi; T B Harris; J M Guralnik
Journal:  J Am Geriatr Soc       Date:  2000-12       Impact factor: 5.562

8.  C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly.

Authors:  T E Strandberg; R S Tilvis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-04       Impact factor: 8.311

Review 9.  Is type II diabetes mellitus a disease of the innate immune system?

Authors:  J C Pickup; M A Crook
Journal:  Diabetologia       Date:  1998-10       Impact factor: 10.122

10.  C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women.

Authors:  Paul M Ridker; Julie E Buring; Nancy R Cook; Nader Rifai
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

View more
  23 in total

1.  Prevalence, components, and correlates of metabolic syndrome (MetS) among elderly Muscovites.

Authors:  Victoria A Metelskaya; Maria A Shkolnikova; Svetlana A Shalnova; Evgeny M Andreev; Alexander D Deev; Dmitri A Jdanov; Vladimir M Shkolnikov; James W Vaupel
Journal:  Arch Gerontol Geriatr       Date:  2011-09-28       Impact factor: 3.250

2.  Shift work aggravates metabolic syndrome development among early-middle-aged males with elevated ALT.

Authors:  Yu-Cheng Lin; Tun-Jen Hsiao; Pau-Chung Chen
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

3.  SHBG, sex hormones, and inflammatory markers in older women.

Authors:  Marcello Maggio; Gian Paolo Ceda; Fulvio Lauretani; Stefania Bandinelli; Anna Maria Corsi; Francesco Giallauria; Jack M Guralnik; Giovanni Zuliani; Chiara Cattabiani; Stefano Parrino; Fabrizio Ablondi; Elisabetta Dall'aglio; Graziano Ceresini; Shehzad Basaria; Luigi Ferrucci
Journal:  J Clin Endocrinol Metab       Date:  2011-01-14       Impact factor: 5.958

4.  Plasma soluble gp130 levels are increased in older subjects with metabolic syndrome. The role of insulin resistance.

Authors:  Giovanni Zuliani; Matteo Galvani; Marcello Maggio; Stefano Volpato; Stefania Bandinelli; Anna Maria Corsi; Fulvio Lauretani; Antonio Cherubini; Jack M Guralnik; Renato Fellin; Luigi Ferrucci
Journal:  Atherosclerosis       Date:  2010-11       Impact factor: 5.162

5.  Evaluation of lasting high levels of CRP among the patients with metabolic syndrome.

Authors:  Osamu Saiki; Makihiko Kuhara; Nozomi Kikuchi; Sanshirou Shiraishi; Hiroshi Uda
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

6.  The metabolic syndrome and inflammation: 
role of insulin resistance and increased adiposity.

Authors:  Wajiha Farooq; Umme Farwa; Faisal Rashid Khan
Journal:  Oman Med J       Date:  2015-03

7.  High sensitivity C-reactive protein associated with different health predictors in middle-aged and oldest old Chinese.

Authors:  Yi Zhai; Xiao Ming Shi; Simon Michael Fitzgerald; Han Zhu Qian; Virginia B Kraus; Melanie Sereny; Perry Hu; Zhao Xue Yin; Jian Wei Xu; Yi Zeng
Journal:  Biomed Environ Sci       Date:  2012-06       Impact factor: 3.118

8.  Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study.

Authors:  Ramin Farzaneh-Far; William S Harris; Sachin Garg; Beeya Na; Mary A Whooley
Journal:  Atherosclerosis       Date:  2008-12-14       Impact factor: 5.162

Review 9.  Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome.

Authors:  Sridevi Devaraj; Simona Valleggi; David Siegel; Ishwarlal Jialal
Journal:  Curr Atheroscler Rep       Date:  2010-03       Impact factor: 5.113

10.  Serum high-sensitivity C-reactive protein as a biomarker in patients with metabolic syndrome: evidence-based study with 7284 subjects.

Authors:  S R Mirhafez; M Ebrahimi; M Saberi Karimian; A Avan; M Tayefi; A Heidari-Bakavoli; M R Parizadeh; M Moohebati; M R Azarpazhooh; H Esmaily; M Nematy; M Safarian; G A Ferns; M Ghayour-Mobarhan
Journal:  Eur J Clin Nutr       Date:  2016-07-27       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.